financetom
Market
financetom
/
Market
/
Heranba Industries makes a strong debut; lists with 43.5% premium at Rs 900 per share
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Heranba Industries makes a strong debut; lists with 43.5% premium at Rs 900 per share
Mar 5, 2021 1:00 AM

Shares of Heranba Industries were listed with a hefty premium of 43.54 percent at Rs 900 on the National Stock Exchange against the issue price of Rs 627 per share. The stock got listed at Rs 900 apiece on the BSE.

Share Market Live

NSE

The IPO of agrichemicals manufacturer Heranba Industries, which was open from February 23-25 was subscribed 83.3 times at a price band of Rs 626-627 per share. The quota for qualified institutional investors was subscribed 67.45 times and the retail portion 11.84 times. The HNI quota saw 271.15 times subscription.

Read here:

Heranba Industries IPO subscribed 83.3 times on last day

The Heranba Industries' IPO comprised an offer-for-sale (OFS) of up to 90.15 lakh equity shares and a fresh issue of Rs 60 crore shares. The net fresh issue proceeds will be utilised for working capital requirements.

Heranba Industries is a crop protection chemical manufacturer and is one of the leading domestic producers of synthetic pyrethroids like cypermethrin, deltamethrin, lambda-cyhalothrin etc.

The company has a strong 19.5 percent market share in the pyrethroids market and caters to over 60 countries. As of FY20, 49 percent of its revenues came from the overseas markets which enabled Heranba to sail through the ups and downs locally.

Brokerages had assigned a ‘Subscribe’ rating to the issue for listing gains and also for the long term, given the company's dominant position in pyrethroids market, better return ratios than peers, reasonable valuations to peers, increasing export opportunity and strong balance sheet with low long term debt.

First Published:Mar 5, 2021 10:00 AM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With Dell Technologies Stock?
What's Going On With Dell Technologies Stock?
Sep 25, 2024
Dell Technologies Inc. ( DELL ) shares are trading higher Wednesday after the stock rejoined the S&P 500 Index on Monday. The company also announced Dell AI for Telecom, a program designed to accelerate AI deployments for communications service providers (CSPs). The Details: The Dell AI for Telecom program is part of the Dell AI Factory and will develop and...
Sector Update: Tech Stocks Mixed Premarket Wednesday
Sector Update: Tech Stocks Mixed Premarket Wednesday
Sep 25, 2024
08:59 AM EDT, 09/25/2024 (MT Newswires) -- Technology stocks were mixed premarket Wednesday as the Technology Select Sector SPDR Fund ( XLK ) was down 0.4% and the SPDR S&P Semiconductor ETF ( XSD ) was up 0.5% recently. Banzai International ( BNZI ) said Tuesday it has agreed to sell about 1.2 million common shares and warrants to purchase...
US STOCKS SNAPSHOT-Wall St opens subdued as investors await Fed rate clues, data
US STOCKS SNAPSHOT-Wall St opens subdued as investors await Fed rate clues, data
Sep 25, 2024
Sept 25 (Reuters) - Wall Street had a subdued start on Wednesday, with investors awaiting further indicators on the state of the economy and potential interest rate reductions, a week after the Federal Reserve initiated its policy relaxation cycle. The Dow Jones Industrial Average rose 27.9 points, or 0.07%, at the open to 42236.09. The S&P 500 fell 0.7 points,...
Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday
Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday
Sep 25, 2024
09:08 AM EDT, 09/25/2024 (MT Newswires) -- Health care stocks were mixed Wednesday as the Health Care Select Sector SPDR Fund (XLV) was up 0.3% and the iShares Biotechnology ETF (IBB) was down 0.2%. Emergent Biosolutions ( EBS ) shares were up 6% in Wednesday's premarket session after saying it received approximately $400 million in orders for its smallpox and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved